Prevalence of the metabolic syndrome and its components in a Spanish community cohort: relation to lifestyle (estuDio de prEvalencia del síndrome meTabólico y sus componEntes: relaCión con el esTilo de vidA)

ISRCTN	ISRCTN19527641
DOI	https://doi.org/10.1186/ISRCTN19527641
Secondary identifying numbers	B2010-1

Submission date: 08/04/2010
Registration date: 20/04/2010
Last edited: 20/04/2010

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Nutritional, Metabolic, Endocrine

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Emilio Ros
Scientific

Endocrinology and Nutrition Service
Hospital Clinic of Barcelona
Barcelona
08036
Spain

Phone	+34 (0)93 2279383
Email	EROS@clinic.ub.es

Study information

Study design	Cross-sectional study
Primary study design	Observational
Secondary study design	Cross-section survey
Study setting(s)	GP practice
Study type	Other
Participant information sheet	Not available in web format, please use contact Anna Munoz [anna.munoz@solvay.com] to request a patient information sheet
Scientific title	Prevalence of the metabolic syndrome and its components in relation to lifestyle in a Spanish community cohort: A cross sectional study
Study acronym	DETECTA
Study objectives	The metabolic syndrome is a cluster of cardio-metabolic risk factors closely linked to abdominal obesity and insulin resistance that considerably increases the risk of cardiovascular disease and diabetes and is reported to affect close of 25% of the population worldwide. The global obesity epidemic, associated with unhealthy diets and sedentariness, is also present in Spain, where a high frequency of the metabolic syndrome is predicted. This topic has only been partially investigated, no data for the overall Spanish population is available, and associations with socioeconomic and lifestyle factors have not been assessed. We hypothesised an overall 30% prevalence of the metabolic syndrome closely related to age, socioeconomic status and lifestyle.
Ethics approval(s)	The institutional review board of the Hospital Clinic of Barcelona approved on the 11th of March 2010 (ref: 2010/5674)
Health condition(s) or problem(s) studied	Obesity; metabolic syndrome; cardiovascular risk factors; lifestyle (including physical exercise and dietary variables)
Intervention	1. Clinical history 2. Anthropometric, adiposity and blood pressure measurements 3. Dietary and physical activity questionnaires
Intervention type	Other
Primary outcome measure	Prevalence and geographical distribution of the metabolic syndrome (updated National Cholesterol Education Program Adult Treatment Panel [NCEP ATP] III definition) by: 1. Gender 2. Age ranges 21-40, 41-60 and 61-80 years
Secondary outcome measures	Prevalence of the metabolic syndrome by 1. Ethnic group (definition in immigrants based on waist circumference cut offs defined for different continents) 2. Socioeconomic status 3. Urban or rural residence 4. Main usual diet components 5. Alcohol consumption 6. Physical activity level 7. Smoking status
Overall study start date	01/05/2010
Completion date	30/04/2011

Eligibility

Participant type(s)	Patient
Age group	Adult
Sex	Both
Target number of participants	10,000
Key inclusion criteria	1. Men and women aged 21-80 years attending family practices throughout Spain 2. Consulting for reasons other than the evaluation or control of cardio-metabolic risk factors or diabetes 3. Blood chemistry including fasting glucose and a lipid profile within the prior 6 months 4. Signed and informed consent
Key exclusion criteria	1. Type 1 diabetes 2. Severe chronic disease 3. Active non-skin cancer or cancer surgery within the previous 2 years 4. Prior organ transplantation and/or immunosuppressive treatment 5. Major surgery within the prior 3 months 6. Major psychiatric illness 7. Alcoholism or drug abuse 8. Known positive HIV status 9. Gain or loss of 5 or more kg within the last 3 months, voluntarily or because of illness 10. Inability to understand the purpose of the study
Date of first enrolment	01/05/2010
Date of final enrolment	30/04/2011

Locations

Countries of recruitment

Spain

Study participating centre

Endocrinology and Nutrition Service

Barcelona
08036
Spain

Sponsor information

Abbott Healthcare S.A. (Spain)
Industry

Avda Diagonal 507
Barcelona
08029
Spain

"ROR"	https://ror.org/01w8r0j67

Funders

Funder type

Industry

Abbott Healthcare S.A. (Spain) - unrestricted grant

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan